What did @thevioletfog actually say?
The creator, a self-described health and wellness writer, shares her personal experience with a prolactinoma, a tumor on the pituitary gland, and roughly 30% hair loss she attributes to it. She says her medical team believes her tumor was "caused by a very high stress lifestyle and suppressing traumatic moments." She also claims that each hair follicle has its own HPA axis, meaning it responds independently to stress signals. Her core message: reducing stress can meaningfully reduce hair shedding. The personal story is genuine and clearly emotional. The science underneath it is more complicated.
To be fair, she does not claim stress is the only factor. She explicitly calls hair loss "multi-factorial" and says stress is "a big piece of the puzzle." That kind of hedging matters. But she also lets the stress-causes-tumors idea sit unchallenged, and that is where things get shaky.
Does the science back this up?
Partly, but with important caveats. The HPA axis claim about hair follicles is actually grounded in real research. The stress-hair loss connection is also legitimate. The prolactinoma origin story is where the evidence falls apart.
Regarding hair follicles and stress: Arck et al. (2006, American Journal of Pathology) demonstrated that hair follicles express corticotropin-releasing hormone (CRH) receptors and can mount local stress responses independent of the systemic HPA axis. That is a real finding and the creator deserves credit for citing it, even loosely. Theoharides et al. (2012, Experimental Dermatology) further showed that psychological stress activates mast cells in the scalp, contributing to telogen effluvium, the type of diffuse shedding most consistent with what she describes.
On prolactinomas and stress: this is where the claim breaks down. Prolactinomas are benign pituitary adenomas. The scientific consensus is that they are not caused by stress. They arise from somatic mutations in lactotroph cells, often involving dysregulation of the dopamine receptor D2 pathway. Melmed (2011, New England Journal of Medicine) outlines the pathophysiology clearly. Chronic stress does elevate prolactin transiently, but there is no peer-reviewed evidence that stress causes these tumors to form. Saying her medical team "believes" stress caused it does not make that claim scientifically valid.
What did they get wrong (or right)?
Right: The HPA axis and hair follicle connection is real, not invented. Stress-related hair shedding is well-documented. Telogen effluvium triggered by physical or psychological stress is one of the most common reversible causes of diffuse hair loss in women. She got the mechanism directionally correct, even if her explanation was simplified.
Wrong: The suggestion that stress, or suppressed trauma, caused her prolactinoma is not supported by evidence. It also carries a subtle harm. When patients believe they caused their own tumor through lifestyle or emotional patterns, it can generate guilt and delay proper evaluation. Prolactinomas require medical management, typically dopamine agonists like cabergoline, and sometimes imaging follow-up for years. Framing the origin as a stress story minimizes that reality.
Also worth flagging: the phrase "team of healers" alongside "doctors" is doing quiet work in this video. Blending clinical and non-clinical practitioners without distinction can blur accountability when medical conditions are involved. A prolactinoma is a diagnosable, treatable medical condition, not a wellness journey.
What should you actually know?
If you are losing hair and stress is a factor in your life, reducing that stress is genuinely worth pursuing, and not just for your hair. But hair loss has many causes, including thyroid dysfunction, iron deficiency, androgenetic alopecia, and elevated prolactin itself, and stress reduction alone will not fix all of them.
Elevated prolactin from a prolactinoma can directly cause hair thinning, along with irregular periods, galactorrhea, and low libido. If a prolactinoma is diagnosed, the hair loss is more likely driven by the hormonal disruption than by stress per se. Treating the prolactinoma with cabergoline or bromocriptine often resolves elevated prolactin levels, and some patients see hair improvement as a result. Fahy et al. (2020, Pituitary) reviewed prolactinoma outcomes and found that dopamine agonist therapy is highly effective in normalizing prolactin in the majority of patients.
The bottom line: stress management is a reasonable, evidence-adjacent recommendation for diffuse hair loss. But it is not a treatment for a pituitary adenoma, and the video does not make that distinction clearly enough.